1832 Asset Management L.P. Organon & Co. Transaction History

1832 Asset Management L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$10.95 - $17.32 $273 - $433	-25 Reduced 29.76%	59 $0
Q3 2023 Nov 13, 2023	BUY	$16.59 - $23.77 $1,393 - $1,996	84 New	84 $1,000
Q2 2023 Aug 11, 2023	BUY	$19.27 - $24.63 $192 - $246	10 Added 16.95%	69 $1,000
Q4 2022 Feb 14, 2023	SELL	$23.31 - $28.61 $139 - $171	-6 Reduced 9.23%	59 $1,000
Q3 2022 Nov 14, 2022	SELL	$23.4 - $34.25 $93 - $137	-4 Reduced 5.8%	65 $2,000
Q2 2022 Aug 15, 2022	SELL	$31.66 - $38.9 $348 - $427	-11 Reduced 13.75%	69 $2,000
Q1 2022 May 16, 2022	BUY	$30.45 - $39.36 $2,436 - $3,148	80 New	80 $3,000

792

203M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.96B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of 1832 Asset Management L.P., based on Form 13F filings with the SEC.

Stay updated on 1832 Asset Management L.P. with notifications on news.